Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06720909 · ClinicalTrials.gov registry record · NA
Mindfulness And Placebo for Pain (MAPP) Study
A NA study of Chronic Pain, sponsored by Arizona State University.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT06720909: Recruiting NA study of Chronic Pain, sponsored by Arizona State University.
NCT06720909 is a NA study of Chronic Pain that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 45 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06720909, a NA study of Chronic Pain, is actively recruiting participants, sponsored by Arizona State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study proposes a three-arm randomized-controlled trial (RCT) that evaluates the feasibility and acceptability of combining a mindfulness-based therapy (MBT) and open-label placebo (OLP) treatment for individuals with chronic pain. Individuals with chronic pain will be recruited to participate in an 8-week trial, with a subsequent 3-month post-treatment follow-up. Participants will be randomly assigned to one of the following three conditions: 1. Mindfulness-Based Stress Reduction (MBSR) 2. OLP treatment 3. combination of MBSR and OLP treatment
Primary Outcome
Feasibility of participant enrollment will be benchmarked at 100% (N=45) proposed participant enrollment during the study.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
- OTHER Open-Label Placebo (OLP)
- OTHER MBSR+OLP
Study Locations (2)
Arizona
- Arizona State University Downtown Phoenix Campus - Phoenix
- Arizona State University - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT06720909 shows while recruiting
NCT06720909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Mindfulness-Based Stress Reduction (MBSR) is the first listed.
NCT06720909 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06720909 about?
NCT06720909 is a clinical study titled "Mindfulness And Placebo for Pain (MAPP) Study". This study proposes a three-arm randomized-controlled trial (RCT) that evaluates the feasibility and acceptability of combining a mindfulness-based therapy (MBT) and open-label placebo (OLP) treatment for individuals with chronic pain. Individuals with chronic pain will be recruited to participate i...
What is the current status of trial NCT06720909?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-01-27. Estimated completion is 2027-03-01.
What conditions does trial NCT06720909 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT06720909?
The interventions under investigation include: Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL), Open-Label Placebo (OLP) (OTHER), MBSR+OLP (OTHER).
Who is sponsoring clinical trial NCT06720909?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06720909 being conducted?
This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06720909's enrollment target sits among peer trials
45 206th of 301 higher than 95 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI